Kirsten
Kirsten Barth-Gremmel, Koln DE
Patent application number | Description | Published |
---|---|---|
20120234585 | Support for Electronic Circuits - Support materials for printing electrically conductive structures by means of inkjet printing with inks which contain conductive particles lead to low resistances for the printed structures without thermal post-treatment when they contain a microporous layer with a mean pore size of less than 100 nm as an outer layer. | 09-20-2012 |
Kirsten Bisgaard-Franzen, Birkerod DK
Patent application number | Description | Published |
---|---|---|
20120259105 | HUMAN PAPILLOMA VIRUS PROBES FOR THE DIAGNOSIS OF CANCER - In one embodiment, the invention relates to a method of detecting cervical cancer, and other types of cancer, using a combination of at least three genomic clones, or fragments thereof, of high risk Human Papilloma Virus. For example, the invention relates to a composition comprising at least three full length genomic clones, or fragments thereof, of high risk Human Papilloma Viruses. | 10-11-2012 |
Kirsten Bjegarde, Bridgewater, NJ US
Patent application number | Description | Published |
---|---|---|
20140350006 | Pyrazolopyridine Derivatives, Preparation Process Therefor And Therapeutic Use Thereof - The invention relates to FGF-inhibiting pyrazolopyrimidine derivatives of general formula (I) to a process for preparing them and to the therapeutic use thereof. | 11-27-2014 |
Kirsten Bjergarde, Tuscon, AZ US
Patent application number | Description | Published |
---|---|---|
20110237641 | SUBSTITUTED PYRAZOLES, COMPOSITIONS CONTAINING THESE, METHOD OF PRODUCTION AND USE - The disclosure relates to a compound of formula (I): | 09-29-2011 |
20110237801 | SUBSTITUTED PYRAZOLES, COMPOSITIONS CONTAINING THESE, METHOD OF PRODUCTION AND USE - The disclosure relates to a compound of formula (I): | 09-29-2011 |
Kirsten Bjergarde, Tucson, AZ US
Patent application number | Description | Published |
---|---|---|
20080227777 | Pyrazolopyridine derivatives as inhibitors of beta-Adrenergic Receptor Kinase 1 - The invention relates to 6-amido substituted pyrazolopyridine derivatives of the formula (I) | 09-18-2008 |
20080261969 | 1,4-Dihydropyridine-Fused Heterocycles, Process for Preparing the Same, Use and Compositions Containing Them - This invention relates to compounds of formula (I) | 10-23-2008 |
20090291984 | SUBSTITUTED PYRAZOLES, COMPOSITIONS CONTAINING THESE, METHOD OF PRODUCTION AND USE - The disclosure relates to a compound of formula (1): | 11-26-2009 |
20130150340 | 6-(4-Hydroxy-phenyl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors - The present invention relates to 1H-pyrazolo[3,4-b]pyridine compounds of the formula I, | 06-13-2013 |
Kirsten Bojsen, Hellerup DK
Patent application number | Description | Published |
---|---|---|
20080274531 | Exo-Specific Amylase Polypeptides, Nucleic Acids Encoding Those Polypeptides And Uses Thereof - This invention relates to amylase polypeptides, and nucleic acids encoding the polypeptides and uses thereof. The amylases of the present invention have been engineered to have more beneficial qualities. Specifically the amylases of the current invention show an altered exospecifity. | 11-06-2008 |
20090047384 | LIPOLYTIC ENZYME VARIANTS - The substrate specificity of a lipolytic enzyme can be modified by making alterations to the amino acid sequence in a defined region of the lipolytic enzyme, so as to increase the level of a desired activity or to decrease the level of an undesired activity. Thus, the inventors have developed lipolytic enzyme variants with a modified amino acid sequence with a substrate specificity which can be tailored for specific uses. | 02-19-2009 |
20100291262 | Lipolytic Enzyme Variants - The substrate specificity of a lipolytic enzyme can be modified by making alterations to the amino acid sequence in a defined region of the lipolytic enzyme, so as to increase the level of a desired activity or to decrease the level of an undesired activity. Thus, the inventors have developed lipolytic enzyme variants with a modified amino acid sequence with a substrate specificity which can be tailored for specific uses. | 11-18-2010 |
Kirsten Bojsen, Ulfborg DK
Patent application number | Description | Published |
---|---|---|
20110212241 | MODIFIED AMYLASES, NUCLEIC ACIDS ENCODING THOSE AMYLASES AND USES THEREOF - This invention relates to nucleic acids encoding amylase polypeptides, the encoded polypeptides and uses thereof. The amylases of the present invention have been engineered to have more beneficial qualities. Specifically, the amylases of the current invention show an altered exo-specificity and/or thermostability. Some embodiments of the invention relate to said polypeptides and nucleic acids and their uses as non-maltogenic exoamylases in producing food products. | 09-01-2011 |
Kirsten Börngen, Koln DE
Patent application number | Description | Published |
---|---|---|
20150148340 | BICYCLICALLY SUBSTITUTED URACILS AND THE USE THEREOF - The present application relates to novel bicyclically substituted uracil derivatives, to processes for preparation thereof, to the use thereof alone or in combinations for treatment and/or prophylaxis of diseases, and to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases. | 05-28-2015 |
Kirsten Bundgaard-Nielsen, Fredensborg DK
Patent application number | Description | Published |
---|---|---|
20090118682 | Reservoir Device With Inspection Aid For Detection Of Drug Condition - The invention provides a reservoir unit with a reservoir arranged within a housing. The reservoir defines an interior adapted to contain a translucent fluid drug, and comprises a first transparent area. A second area is associated with the reservoir and arranged substantially opposite the first area, the second area comprising a visually non-uniform portion. The housing comprises an inspection portion allowing a user to inspect a portion of the reservoir through the first area with the second area serving as a background, the second area thereby serving as an aid for evaluating a condition of a drug contained in the reservoir, e.g. fibrillated insulin. | 05-07-2009 |
Kirsten Cabanas-Holmen, Hovik NO
Patent application number | Description | Published |
---|---|---|
20110186424 | CONTACTING DEVICE - The present invention relates to a device for contacting a wafer during submersion in a liquid. The device comprises a main body fixed to a transportation device; an electrical contact for contacting the wafer and a pressure element for pressing the electrical contact towards the wafer. | 08-04-2011 |
Kirsten Cicotte, Albuquerque, NM US
Patent application number | Description | Published |
---|---|---|
20140121328 | Polymer Scaffold Degradation Control Via Chemical Control - A variety of polymers and copolymers suitable for use as biologically compatible constructs and, as a non-limiting specific example, in the formation of degradable tissue scaffolds as well methods for synthesizing these polymers and copolymers are described. The polymers and copolymers have degradation rates that are substantially faster than those of previously described polymers suitable for the same uses. Copolymers having a synthesis route which enables one to fine tune the degradation rate by selecting the specific stoichiometry of the monomers in the resulting copolymer are also described. The disclosure also provides a novel synthesis route for maleoyl chloride which yields monomers suitable for use in the copolymer synthesis methods described herein. | 05-01-2014 |
20140242148 | ANTIMICROBIAL MATERIALS AND METHODS - The invention provides methods and materials for decontamination of surfaces and fabrics, such as non-woven fabrics, that are contaminated with infestations of microorganisms such as bacteria. Biocidal oligomers having conjugated oligo-(aryl/heteroaryl ethynyl) structures and comprising at least one cationic group can be used to decontaminate infested surfaces in the presence of oxygen and, optionally, illumination. Fibers incorporating biocidal oligomers having conjugated oligo-(aryl/heteroaryl ethynyl) structures and comprising at least one cationic group, wherein the oligomer is physically associated with or covalently bonded to, or both, the fiber-forming polymer can be used to form non-woven mats. Biocidal non-woven mats prepared by methods of the invention, incorporating the biocidal oligomers, can be used to suppress bacterial growth in wound and surgical dressings and personal hygiene products. | 08-28-2014 |
20140319740 | Electrospun Fiber Mats from Polymers Having a Low Tm, Tg, or Molecular Weight - Methods and apparatus for forming non-woven fiber mats from polymers and monomers that are traditionally difficult to use for fiber formation are shown and described. Applicable techniques include electrospinning and other traditional fiber formation methods. Suitable polymers and monomers include those having low molecular weight, a low melting point, and/or a low glass transition temperature. | 10-30-2014 |
Kirsten Clark, Las Vegas, NV US
Patent application number | Description | Published |
---|---|---|
20130316797 | TOTAL MONEY MANAGEMENT SYSTEM - A total money management system for integrating numerous stand-alone components designed to validate, track and secure gaming currency from the table to back-of-house is provided. Utilizing RFID enabled casino currency, an RFID chip tray, a bill validator, RFID readers and antennas, inventory system and chip authentication network, the total money management system of the present disclosure provides casinos with a cash and chip tracking and reporting tool that will improve table performance and streamline the numerous at-table and back-of-house manual money management processes and procedures. | 11-28-2013 |
20140332597 | VALUE TOKEN WITH SLUG HAVING RFID AND ELECTROMAGNETIC DETECTION FEATURES - Value tokens, e.g. gaming chips, are formed with a slug having an RFID microchip embedded or encapsulated inside and an EM coil either embedded or encapsulated inside or wrapped around the periphery of the slug. The slug is formed by injection molding two plastic halves with a spacing therebetween for accepting the RFID microchip. The plastic halves are formed from weighted plastic including fillers such as copper, brass and/or tungsten to add extra weight to the plastic halves. The EM coil is placed on the same radius as the RFID antenna within the gaming chip or at a radius outside the RFID antenna to as to minimize interference between the RFID and EM signals by minimizing the metal in the EM field. For example, the EM coil may be wound within a groove around the outer periphery of the slug. | 11-13-2014 |
20140339107 | RFID PLAQUE BOX - An RFID plaque box provides secure storage and protection of value tokens (e.g., gaming plaques and jetons) of all sizes and shapes (e.g., rectangular, square, oval or round) and delivers real-time counting and movement details in both high and low frequency RF environments. The RFID plaque box allows plaques or jetons to be accounted for as part of the table's inventory along with the RFID chip tray's inventory (when installed). The RFID plaque box is provided as a fixed storage area that is situated below the plan of the gaming table alongside the RFID chip tray (when provided) with a lid very similar to that of the RFID chip tray or provided in a pop-up mechanism whereby the RFID plaque box is integrated into a gaming table such that when the top surface of the RFID plaque box is pushed, the RFID plaque box will pop-up to lift the stacks of plaques or jetons for access. | 11-20-2014 |
Kirsten Deist, Westdorf DE
Patent application number | Description | Published |
---|---|---|
20110113494 | Serine Hydroxymethyltransferase as Target for Herbicides - The present invention relates to serine hydroxymethyltransferase (E.C. 2.1.2.1) as novel target for herbicides, and to nucleic acid sequences encoding a polypeptide with the biological activity of a serine hydroxymethyltransferase, which, when not present, bring about growth retardation symptoms and chlorotic leaves, comprising the nucleic acid sequence SEQ ID No:3, and functional equivalents of the abovementioned nucleic acid sequence or the nucleic acid sequence SEQ ID NO:7 and functional equivalents of the abovementioned nucleic acid sequence. Moreover, the present invention relates to the use of the abovementioned nucleic acid sequences, of functional analogs of the SEQ ID NO:3 or SEQ ID NO:7 or of polypeptides encoded by one of the abovementioned nucleic acid sequences in a method for identifying herbicidally active compounds which inhibit serine hydroxymethyltransferases, and to the use of these compounds which have been identified by the method as herbicides. | 05-12-2011 |
Kirsten Doogue, Manchester, NH US
Patent application number | Description | Published |
---|---|---|
20120086090 | METHODS AND APPARATUS FOR PASSIVE ATTACHMENT OF COMPONENTS FOR INTEGRATED CIRCUITS - Methods and apparatus provide a sensor including a component coupled to the leadframe such that the component is an integrated part of the IC package. | 04-12-2012 |
Kirsten Doogue, Bedford, NH US
Patent application number | Description | Published |
---|---|---|
20150285874 | Methods and Apparatus for Passive Attachment of Components for Integrated Circuits - Methods and apparatus for a sensor having a die supporting a magnetic field sensor element, a leadframe having opposed first and second surfaces and leadfingers, a passive component coupled to the first and second ones of the leadfingers such that the component is an integrated part of an IC package, and a magnet adjacent to the second surface of leadframe to back bias the magnetic field sensor element. | 10-08-2015 |
Kirsten Ebbehoj, Naerum DK
Patent application number | Description | Published |
---|---|---|
20090208565 | STABILIZED EXENDIN-4 COMPOUNDS - The present invention discloses compositions comprising a stabilized Exendin-4 (1-39) and related compounds. The invention describes stabilized Exendin-4 agonists that include at least one modified amino acid residue particularly at positions Gln13, Met14, Trp25, or Asn28 of the Exendin-4 (1-39) molecule. Disclosed are preferred modifications of deaminated, hydrolyzed, oxidized, or isomerized reaction products of the specified amino acid residues corresponding to the same positions in the Exendin-4 (1-39) molecule. The invention also relates to methods of making and using the stabilized Exendin compounds, such as for the treatment of diabetes. | 08-20-2009 |
Kirsten Ebbehøj, Naerum DK
Patent application number | Description | Published |
---|---|---|
20100029569 | Pharmaceutical Formulation - The invention relates to aqueous pharmaceutical formulations comprising human growth hormone, histidine, poloxamer, phenol, and mannitol. | 02-04-2010 |
Kirsten Eibl-Lindner, Munchen DE
Patent application number | Description | Published |
---|---|---|
20120027812 | INTRAOCULAR LENSES TREATED WITH ALKYLPHOSPHOCHOLINES FOR PHARMACOLOGICAL AFTERCATARACT PROPHYLAXIS - The invention relates to ophthalmological implants which comprise alkylphosphocholines. Implants of this type may in particular advantageously be used for the prophylaxis of aftercataract. | 02-02-2012 |
Kirsten Fletter, Omaha, NE US
Patent application number | Description | Published |
---|---|---|
20130216659 | FOOD PRODUCT AND COATING - The coating can have a low-sweetness perception. During manufacturing and processing, the coating maintains a flowability to allow a glaze state of the coating to be applied to a food. Upon cooling, the glaze state of the coating forms a glass state that provides a low-sweetness impact which facilitates application of savory taste perceptions. | 08-22-2013 |
20130216668 | FOOD PRODUCT AND COATING - The coating can have a low-sweetness perception. During manufacturing and processing, the coating maintains a flowability to allow a glaze state of the coating to be applied to a food. Upon cooling, the glaze state of the coating forms a glass state that provides a low-sweetness impact which facilitates application of savory taste perceptions. | 08-22-2013 |
20130216677 | FOOD PRODUCT AND COATING - The coating can have a low-sweetness perception. During manufacturing and processing, the coating maintains a flowability to allow a glaze state of the coating to be applied to a food. Upon cooling, the glaze state of the coating forms a glass state that provides a low-sweetness impact which facilitates application of savory taste perceptions. | 08-22-2013 |
Kirsten Fry-Sanchez, Evergreen, CO US
Patent application number | Description | Published |
---|---|---|
20090327121 | MONETARY GIFT REGISTRY METHODS AND SYSTEMS - A method of operating a monetary gift registry includes registering one or more recipients with the monetary gift registry and creating an account for each registered recipient. Each account has a unique account identifier. Transfers of monetary value are received from one or more senders, each transfer of value accompanied by the unique identifier of one of the accounts. The deposits are accumulated into the respective accounts based at least in part on unique identifiers, and funds from at least one account are distributed. Funds may be distributed to at least one registered recipient for whom an account was created, or to a third-party merchant. At least one transfer of monetary value or distribution of funds is capable of being performed through a consumer-oriented money transfer network, or both | 12-31-2009 |
Kirsten Fuchs, Kissing DE
Patent application number | Description | Published |
---|---|---|
20090278456 | Mercury source - The invention relates to a mercury source for a low-pressure discharge lamp comprising an amalgam body which is arranged on a front surface of a wire or enclosed in a perforated structure. The amalgam body or the perforated structure is provided with a protective coating with a getter effect. The invention enables a simple production process to be implemented with low costs in terms of materials. | 11-12-2009 |
20090322223 | STARTER MEMBER FOR A LOW-PRESSURE DISCHARGE LAMP - Disclosed is a starter member to which a mercury-absorbing layer is applied and which can be used in low-pressure mercury discharge lamps. A starter member for a low-pressure amalgam discharge lamp comprises a mercury-absorbing layer on a base. A coating layer which is provided on the mercury-absorbing layer has a getter effect and prevents the material of the mercury-absorbing layer from coming off. | 12-31-2009 |
20110037408 | Method for Operating a Gas Discharge Lamp and Lighting System Comprising a Gas Discharge Lamp - A method for operating a discharge lamp ( | 02-17-2011 |
Kirsten Harmrols, Saarbrücken DE
Patent application number | Description | Published |
---|---|---|
20150111298 | Method for Producing Recombinant 11-De-O-Methyltomaymycin - The present invention provides a tomaymycin biosynthetic gene cluster of | 04-23-2015 |
Kirsten Hoppert, Halle DE
Patent application number | Description | Published |
---|---|---|
20090057188 | CARRY CASE - A carry case is provided for a portable analyte measuring device, the carry case having opposing sides delimiting an interior space that is closed at one end and provided with an opening at the other end. According to certain embodiments of the present invention, the carry case is provided with an interior flap that is fastened at a distance from the closed end at one of the opposing sides and that can be swung from a first position in which a first side of the flap faces one of the opposing sides to a second position, in which the flap divides the interior space of the carry case and faces with the first flap side the closed end of the interior space. | 03-05-2009 |
Kirsten Huber, Mainz DE
Patent application number | Description | Published |
---|---|---|
20110133505 | METHOD AND COUPLING DEVICE FOR STOWING A MOTOR VEHICLE SEAT - A storage compartment is provided for a motor vehicle that includes, but is not limited to a motor vehicle seat. The storage compartment further includes, but is not limited to a movable element, a cargo space in the motor vehicle defined with the movable element that is at least partially bordered by the motor vehicle seat and situated with respect to the motor vehicle seat, and a wall bordering the cargo space in at least one direction and detachably coupled with the movable element with a coupling element so that the wall moves with the movable element. | 06-09-2011 |
20120256461 | BACKREST ADJUSTMENT DEVICE FOR A VEHICLE SEAT OR A VEHICLE BENCH SEAT - A backrest adjustment device is provided for a vehicle seat or a vehicle bench seat, in particular for a motor vehicle seat or a motor vehicle bench seat, in which a backrest part is connected to a seat part via an adjustment and fixing device, which has a fixing, which is disengaged for the inclination adjustment of the backrest part, the fixing of the adjustment and fixing device being disengaged by an electromechanical actuator. | 10-11-2012 |
Kirsten Itzold, Mountain View, CA US
Patent application number | Description | Published |
---|---|---|
20150194277 | TWO PART KEY CAP FOR USE IN KEYBOARD KEYS AND METHODS FOR THEIR MANUFACTURE - A key assembly is for use in a keyboard of the type including a key guide having a planar translation effecting (PTE) feature. The key assembly includes a key base having a PTE mating feature configured to interact with the PTE feature during a key press, and a key cap configured to be attached to the key base. The key base is made of a first material and the key cap is made of a second material different from the first material. A conductive portion and/or a magnet may be wedged between or secured within the key base or the key cap. | 07-09-2015 |
Kirsten Karchmer, Austin, TX US
Patent application number | Description | Published |
---|---|---|
20160140314 | CONCEIVABLE BASAL BODY TEMPERATURES AND MENSTRUAL CYCLE - The present invention discloses software programs, systems and methods for increasing the chances of users conception by maximizing the user's fertility potential by providing a software program that combines identifying the underlying causes of infertility and using best practices as described by current medical literature for fertility changes along with herbal recommendations to provide personalized wellness recommendations that give the individual user the power to improve their natural fertility. | 05-19-2016 |
Kirsten Knull, Alexandria, VA US
Patent application number | Description | Published |
---|---|---|
20090109798 | Events recordation device, system and method for caregivers - In accordance with at least one exemplary embodiment, an events recordation device, system and method is disclosed. The events recordation device can include an electronic module having a microprocessor, memory, and a display operatively connected. More than one data entry mechanism can be connected to and can form part of the electronic module for entering data. A first mode of operation can be configured to record and display feeding events data. A second mode of operation can be configured to record and display medication events data. A third mode of operation can be configured to record and display sleep events data. | 04-30-2009 |
Kirsten Kopitzke, Hamburg DE
Patent application number | Description | Published |
---|---|---|
20090119431 | Multi-purpose flight attendant panel - A flight attendant panel, in which a plurality of computer units can be coupled to a common input/output device by a circuitry. One of the computer units is designated as the master computer unit and controls the circuitry in order to specify which of the computer units should be coupled to the input/output device. The actuation of a switch makes it possible to once again return the flight attendant panel into an original state, in which the master computer unit is coupled to the input/output device by the circuitry. | 05-07-2009 |
Kirsten Leineweber, Velbert-Neviges DE
Patent application number | Description | Published |
---|---|---|
20140187491 | RELAXIN FUSION POLYPEPTIDES AND USES THEREOF - The present invention provides Relaxin fusion polypeptides A-L-B with a non-wild type array of the Relaxin A-chain and Relaxin B-chain, wherein the A- and B-chains are connected by a linker peptide. The invention further provides Relaxin fusion polypeptides with extended half-life. Furthermore, the invention provides nucleic acid sequences encoding the foregoing fusion polypeptides, vectors containing the same, pharmaceutical compositions and medical use of such fusion polypeptides. | 07-03-2014 |
Kirsten Leineweber, Velbert-Langenberg DE
Patent application number | Description | Published |
---|---|---|
20150329613 | FUSION POLYPEPTIDES AND USES THEREOF - The present invention provides Relaxin fusion polypeptides with extended half-life. Thereby, the half-life extending parts are either the Fc moiety of the human IgG2 or of the human IgG4. Furthermore, the invention provides nucleic acid sequences encoding the foregoing fusion polypeptides, vectors containing the same, pharmaceutical compositions and medical use of such fusion polypeptides. | 11-19-2015 |
Kirsten Luetzeler, Muenster DE
Patent application number | Description | Published |
---|---|---|
20100003524 | COMPOSITE PART MADE OF A MULTI-LAYER FILM AND A SUBSTRATE BASED ON A POLYCARBONATE - A composite part is composed of | 01-07-2010 |
20100003534 | COMPOSITE PART CONSISTING OF A MULTI-LAYER FILM AND A SUBSTRATE BASED ON A POLYALKYL(METH)ACRYLATE - A composite part is composed of | 01-07-2010 |
20100055425 | COMPOSITE PART CONSISTING OF A FILM AND A SUBSTRATE BASED ON AN AMORPHOUS POLYAMIDE - A film which comprises a layer composed of a moulding composition composed of a semicrystalline polyamide whose enthalpy of fusion is at least 8 J/g is used for production of a composite part with a substrate composed of a moulding composition composed of a substantially amorphous polyamide whose enthalpy of fusion is less than 8 J/g. | 03-04-2010 |
20100062272 | TRANSPARENT PART - A transparent component, which comprises the following subcomponents: | 03-11-2010 |
20110045269 | COMPONENT WITH TOP LAYER OF A PA613 MOULDING COMPOUND - A component which comprises the following components: I. a top layer of a moulding compound which contains at least 50% by weight of PA613 and II. a substrate of a thermoplastic moulding compound has a surface with high scratch resistance and high chemical resistance. | 02-24-2011 |
20110244209 | TRANSPARENT MOLDING COMPOSITION - A polyamide molding composition which can be used for production of a printable or printed item contains a) at most 90 parts by weight of a polyamide obtained from a lactam or from an amino carboxylic acid having at least 10 carbon atoms; and b) from 10 to 100 parts by weight of PA1010, wherein a total of components a) and b) is 100 parts by weight. | 10-06-2011 |
20120196113 | FILM MADE OF POLYARYLEETHERKETONE - The invention relates to a molding compound, comprising the following components: a) 60 to 96% by weight polyaryletherketone, b) 2 to 25% by weight hexagonal bornite, and c) 2 to 25% by weight talcum, wherein the sum of the parts by weight of components a), b), and c) is 100. Said compounds can be used to produce a film having a thickness of 5 to 1200 μm, which is suitable for producing dimensionally stable circuit boards. | 08-02-2012 |
Kirsten Maarbjerg, Odense DK
Patent application number | Description | Published |
---|---|---|
20090139034 | FUTON MATTRESS - A futon mattress ( | 06-04-2009 |
Kirsten Mertz, Stuttgart DE
Patent application number | Description | Published |
---|---|---|
20090036415 | Identification and treatment of estrogen responsive prostate tumors - The present invention is directed to specific chromosomal rearrangements that are associated with prostate tumors that respond to compounds acting at estrogen receptors. Patients having the TMPRSS2-ERG fusion, may be treated with agonists of the estrogen beta receptor or antagonists of the estrogen alpha receptor. | 02-05-2009 |
Kirsten Moselund, Zurich CH
Patent application number | Description | Published |
---|---|---|
20090146194 | SEMICONDUCTOR DEVICE AND METHOD OF MANUFACTURING A SEMICONDUCTOR DEVICE - The local bending of a silicon nanowire induces tensile strain in the wire due to the stretching of the silicon lattice. This in turn enhances the mobility of the free carriers (electrons) in the direction of transport along the wire. Thus, for example, when Gate-All-Around MOSFETs are fabricated along the nanowire, the mobility enhancement will translate into an improvement in the performance (current drive, speed) of the silicon nanowire MOSFETs. In summary, a semiconductor device comprises a substrate and a nanowire in connection with the substrate at a drain and at a source region, and the nanowire is bent to achieve enhanced mobility of charge carriers. | 06-11-2009 |
Kirsten Moselund, Lausanne CH
Patent application number | Description | Published |
---|---|---|
20090072279 | Capacitor-less memory and abrupt switch based on hysteresis characteristics in punch-through impact ionization mos transistor (PI-MOS) - The present invention exploits the impact ionization induced by drain voltage increase and the onset of a bipolar parasitic in an Ω-gate field effect metal oxide insulator transistor (called PI-MOS), in order to obtain a memory effect and abrupt current switching. | 03-19-2009 |
Kirsten Norrelund, Ballerp DK
Patent application number | Description | Published |
---|---|---|
20150133542 | METHOD OF TOPICALLY TREATING ACTINIC KERATOSIS WITH INGENOL MEBUTATE CYCLE THERAPY - The present invention relates to cyclic or repeated use of the ingenol mebutate for topical treatment of actinic keratosis lesions. Generally speaking, the present invention comprises a first ingenol mebutate treatment cycle and a second ingenol mebutate treatment cycle, wherein the first treatment cycle topically treats a treatment area with a topical gel formulated with ingenol mebutate at a selected dosage strength for a specified treatment regimen, and the second ingenol mebutate treatment cycle comprises topically re-treating the treatment area with the same topical ingenol mebutate gel for the same specified treatment regimen, if following the first treatment cycle, the treatment area failed to clear or failed to remain clear of AK lesions. The present invention further relates to spot or individual lesion therapy in the treatment area following the topical bi-cyclic therapy with ingenol mebutate. | 05-14-2015 |
Kirsten Pelz-Stelinski, Lake Alfred, FL US
Patent application number | Description | Published |
---|---|---|
20130266535 | METHYL SALICYLATE-BASED ATTRACTANTS FOR VECTORS OF CITRUS GREENING DISEASE - The present invention is directed to an insect attractant having an amount of methyl salicylate effective to attract a plurality of vectors of | 10-10-2013 |
Kirsten Plitt, Mannheim DE
Patent application number | Description | Published |
---|---|---|
20110092600 | PHARMACEUTICAL COMPOSITIONS COMPRISING AMINOCYCLOHEXANE DERIVATIVES - The present invention relates to pharmaceutical compositions comprising 1-aminocyclohexane derivatives and a cyclodextrin, which compositions exhibit advantageous safety, convenience, and dosing characteristics. The compositions of the instant invention find particular application in the treatment of various diseases and conditions of the CNS, including those involving the impairment of cognitive function or dementia, such as Alzheimer's disease. | 04-21-2011 |
Kirsten Povel, Hamburg DE
Kirsten Pugh, Calgary CA
Patent application number | Description | Published |
---|---|---|
20110174488 | ACCELERATED START-UP IN SAGD OPERATIONS - A method of initiating or accelerating the establishment of fluid communication between horizontal wells located in a formation of very limited fluid mobility, such as an oil sand at original temperature or an infill well completed in an immobile hydrocarbon region located between surrounding well patterns in which a gravity-dominated recovery process is or has been operated. | 07-21-2011 |
Kirsten Radau, Ingelheim Am Rhein DE
Patent application number | Description | Published |
---|---|---|
20100009984 | AEROSOL FORMULATIONS FOR THE INHALATION OF BETA-AGONISTS - A pharmaceutical formulation, comprising: | 01-14-2010 |
20110190284 | AEROSOL FORMULATIONS FOR THE INHALATION OF BETA-AGONISTS - A pharmaceutical formulation, comprising: | 08-04-2011 |
Kirsten Radau, Ingelheim DE
Patent application number | Description | Published |
---|---|---|
20120058980 | AEROSOL FORMULATION FOR THE INHALATION OF BETA AGONISTS - The present invention relates to a propellant-free aerosol formulation which contains one or more compounds of general formula 1, | 03-08-2012 |
Kirsten Rasanen, New York, NY US
Patent application number | Description | Published |
---|---|---|
20160142779 | SYSTEMS AND METHODS FOR ACQUIRING, CATEGORIZING AND DELIVERING MEDIA IN INTERACTIVE MEDIA GUIDANCE APPLICATIONS - Systems and methods are discussed for providing guidance for Internet-delivered media. In some embodiments, information on available media on the Internet, is gathered. The information is associated with existing media guidance data. The associations enable a media guidance application to identify relevant online media and to display listings in a user-friendly way. A user interface for an online media guidance application is also provided. The user interface allows a user to narrow down the large amount of Internet-delivered media in a systematic way according to criteria that interests a user. | 05-19-2016 |
Kirsten Raun, Lyngby DK
Patent application number | Description | Published |
---|---|---|
20090149512 | Use of Ghrelin Antagonists to the Treatment of Certain CNS Diseases - Ghrelin antagonists can be used for the treatment of certain CNS disorders. For example, certain oxadiazoles, preferably such being ghrelin antagonists, can be used to treat obesity, e.g., drug-induced obesity. | 06-11-2009 |
20100022446 | Use of Peptides in Combination with Surgical Intervention for the Treatment of Obesity - The present invention relates to novel peptide compounds which are effective in modulating one or more melanocortin receptor types, to the use of the compounds in therapy, to methods of treatment comprising administration of the compounds to patients in need thereof, and to the use of the compounds in the manufacture of medicaments. The compounds of the invention are of particular interest in relation to the treatment of obesity as well as a variety of diseases or conditions associated with obesity. | 01-28-2010 |
20100222277 | Regulation of Food Preference Using GLP-1 Agonists - GLP-1 agonists selectively decrease the amount of food intake, wherein the food has a high glycemic index or wherein the amount of mono- and di-saccharides together constitute a large proportion of the total amount of carbohydrates. | 09-02-2010 |
20120245083 | Derivatives of CGRP - Acylated CGRP compounds with a linker have prolonged action and are valuable as medicaments. | 09-27-2012 |
20140018290 | LEPTIN DERIVATIVES - The invention relates to Leptin derivatives, compositions and therapeutic use there-of. | 01-16-2014 |
20150038417 | GLP-1 Agonists - A method for the prevention or treatment of alcoholism and drug addiction comprising administering to a subject in need thereof a therapeutically effective amount of a GLP-1 agonist. | 02-05-2015 |
Kirsten Rothmann-Cosic, Berlin DE
Patent application number | Description | Published |
---|---|---|
20090023131 | CIRCUIT ARRANGEMENT FOR INJECTING NUCLEIC ACIDS AND OTHER BIOLOGICALLY ACTIVE MOLECULES INTO THE NUCLEUS OF HIGHER EUCARYONTIC CELLS USING ELECTRICAL CURRENT - The invention relates to a novel circuit arrangement for electrotransfection or electrofusion, which enables the transportation of DNA and/or other biologically active molecules to the nucleus of higher eukaryotic cells or the fusion of cells, independent of cell division and with reduced cell mortality. | 01-22-2009 |
20090252721 | Differentially expressed tumour-specific polypeptides for use in the diagnosis and treatment of cancer - The invention relates to agents and methods for the diagnosis, prognosis and treatment of cancer. Specifically, the invention relates to the use of nucleic and amino acid sequences encoding transmembrane superfamily member 6 (TM4SF6), synaptophysin like protein (SYPL), stomatin like 2 (STOML2), Ras related GTP binding protein RAGA), nucleotide sensitive chloride channel 1A (CLNS1A), prion protein (p27-30) (PRNP), guanine nucleotide binding protein beta 2-like 1 (GNB2L1), guanine nucleotide binding protein 4 (GNG4), integral membrane protein 2B (ITM2B), integral membrane protein 1 (ITM1), transmembrane 9 superfamily member 2 (TM9SF2), opiate receptor-like 1 protein (OPRL1), low density lipoprotein receptor-related protein 4 (LRP4), human glomerular epithelial protein 1 (GLEPP1), toll-like receptor 3 (TLR3), and/or zona pellucida glycoprotein 3A (ZP3) for the diagnosis of both early and late stage non-steroid specific cancers, cancer prognosis, as well as screening for therapeutic agents that regulate the gene expression and/or biological activity of said proteins. This invention further relates to the biological technologies designed to inhibit the gene expression and/or biological activity of said proteins including using agents identified in screening assays described herein, vector delivery of antisense polynucleotide sequences, and antibody targeting of said proteins. In specific embodiments, the proteins are of human origin. | 10-08-2009 |
20110117654 | BUFFER SOLUTION FOR ELECTROPORATION AND A METHOD COMPRISING THE USE OF THE SAME - A method for introducing biologically active molecules into animal or human cells using an electric current includes suspending the cells and dissolving the biologically active molecules in a buffer solution including HEPES and at least 10 mmol×1 | 05-19-2011 |
Kirsten Sartingen, Brueggen DE
Patent application number | Description | Published |
---|---|---|
20110124542 | Composition Containing Surfactants and Having a Special Emulsifier Mixture - Clear composition comprising surfactants, one or more oil component(s), and a mixture of solubilizers chosen from (a) ethoxylated fatty alcohols, (b) ethoxylated hydrogenated castor oils, and (c) ethoxylated mono-, di- or triglycerol esters in a ratio of components (a):(b):(c) in the range of 1:(2-4):(3-4). The compositions provide a particular suspension stability and viscosity stability and are suitable as a cosmetic composition for cleaning skin and hair. | 05-26-2011 |
20130217748 | COSMETIC CLEANING AGENT - A cosmetic cleaning agent, comprises: in a cosmetic carrier: (a) greater than or equal to 12 wt % of a surfactant mixture comprising (i) at least one anionic surfactant and (ii) at least one zwitterionic/amphoteric surfactant in a weight ratio (i):(ii) of (2,5-3,5):1; (b) at least one cationic copolymer comprising (meth)acrylamide and dialkyldiallylammonium salts as the monomers; and (c) at least one opacifier and/or one pearlizer; wherein the quantities are based on the total weight of the cleaning agent. A method of producing a stable turbid and/or pearlescent cosmetic cleaning agent comprises: combining (a) at least one anionic surfactant and (b) at least one zwitterionic and/or an amphoteric surfactant to produce a surfactant combination; and combining, at room temperature, the surfactant combination with, (c) at least one cationic copolymer comprising (meth)acrylamide and dialkyldiallylammonium salts as the monomers, and (d) at least one opacifier and/or one pearlizer. | 08-22-2013 |
20150118177 | METHOD FOR PRODUCING A CARE COSMETIC CLEANING AGENT - A method for manufacturing a cosmetic cleaning agent includes the steps of a) providing an aqueous dispersion that includes at least one inorganic pigment and/or at least one opacifier and/or luster agent; b) providing a preparation that includes at least one acrylate homo- or copolymer; c) mixing the aqueous dispersion from method step a) with the preparation from method step b); d) providing an O/W emulsion; e) mixing the O/W emulsion from method step d) with the mixture from method step c); f) providing a cosmetically acceptable carrier that includes at least one surfactant; g) mixing the cosmetically acceptable carrier from method step f) with the mixture from method step e). | 04-30-2015 |
Kirsten Schicke, Kaltenkirchen DE
Patent application number | Description | Published |
---|---|---|
20120309008 | Method and Laboratory Apparatus for Processing Laboratory Samples - The present invention relates to methods for solidifying a sample and to an apparatus, in particular for use in a laboratory, for performing a work step on a sample, comprising a first temperature section adjustable to a first temperature and to which the sample is thermally connectable, a second temperature section with a second temperature, and a solidification device for the solidification of the sample, wherein the sample is transferable at least partially to a solid state of matter such that leakage of the sample is prevented, and wherein the solidification device comprises a trigger device to trigger the solidification of the one sample at a start time, a heat transport device for transporting heat between said first temperature section and said second temperature section during a tempering period starting at said start time, and a control device for controlling the tempering period and the first temperature. | 12-06-2012 |
Kirsten Schmaler, Tettau DE
Patent application number | Description | Published |
---|---|---|
20120009835 | Sheet material for a folding wall of a transition device and the method for the production of such sheet material - The subject of this invention is a sheet of material for the manufacture of a folding wall of a transition between two articulated vehicle units, as well as the folding wall of a passenger boarding bridge or passenger stairs, wherein the sheet material has at least one reinforcement element, with the reinforcement element is coated on both sides with a plastic layer, wherein the at least one reinforcement element has on one side a coating based on a silicone rubber and on the other side a coating based on an organic rubber. | 01-12-2012 |
Kirsten Schönemann, Mulheim An Der Ruhr DE
Patent application number | Description | Published |
---|---|---|
20140057819 | USE OF BLOCK-COPOLYMERIC POLYALKYLENE OXIDES AS FRICTION REDUCERS IN SYNTHETIC LUBRICANTS - The invention relates to the use of block copolymers containing at least a block of aromatic oxyalkylene groups and a block of nonaromatic oxyalkylene groups as friction-reducing additive and also compositions and lubricant formulations containing the block copolymers of the invention. | 02-27-2014 |
Kirsten Siebertz, Nidderau DE
Patent application number | Description | Published |
---|---|---|
20150072080 | POLYMERIZATES THAT CAN BE PRODUCED BY THE EMULSION POLYMERIZATION OF FUNCTIONALIZED POLYURETHANE NANOPARTICLES AND RADICALLY CURABLE MONOMERS, A METHOD FOR THE PRODUCTION OF SAID POLYMERIZATES, AND USE OF SAID POLYMERIZATES - The invention relates to polymerizates that can be obtained by a) reacting at least one polyisocyanate with at least one polyol and optionally at least one radically curable monomer A with groups reactive toward isocyanate in at least one radically curable monomer B to form polyurethane particles having an average diameter of less than 40 nm, preferably less than 20 nm, and especially preferably less than 10 nm and an average number of radically curable functionalities in a range of 2 to 4, preferably 2 to 3, and b) emulsion polymerizing the product obtained under a). By means of the emulsion polymerization, larger cross-linked polyurethane/polymer hybrid dispersions are produced, in which the nanoparticles act as a connecting member between the polymer areas and the polyurethane components. This structure results in improved chemical resistance and significantly improved mechanical properties in comparison with traditional polyurethane dispersions, in which polyurethane nanoparticles are subsequently dispersed in polyacrylates, for example by means of an acetone method. Furthermore, the content of polyurethane in the polymer can be better controlled by means of this production method. The invention further relates to a method for producing such polymerizates and the use of such polymerizates as adhesives or coatings, in particular for textiles, or as paints, or for films and foils. | 03-12-2015 |
Kirsten Spannhoff, Lugwigshafen DE
Patent application number | Description | Published |
---|---|---|
20140005457 | CATALYST AND PROCESS FOR THE CONVERSION OF OXYGENATES TO OLEFINS | 01-02-2014 |
Kirsten Spannhoff, Mannheim DE
Patent application number | Description | Published |
---|---|---|
20130197288 | PROCESS FOR THE CONVERSION OF SYNTHESIS GAS TO OLEFINS - The present invention relates to a process for converting a gas mixture comprising CO and H | 08-01-2013 |
20140005455 | PROCESS FOR THE CONVERSION OF OXYGENATES TO OLEFINS | 01-02-2014 |
20140005456 | CATALYST COATING AND PROCESS FOR THE CONVERSION OF OXYGENATES TO OLEFINS | 01-02-2014 |
Kirsten Spannhoff, Ludwigshafen DE
Patent application number | Description | Published |
---|---|---|
20140135556 | Production and Use of a Zeolitic Material in a Process for the Conversion of Oxygenates to Olefins - Described is a process for the production of a zeolitic material having an MFI, MEL, and/or MWW-type framework structure comprising YO | 05-15-2014 |
20140142361 | Process for the Conversion of Oxygenates to Olefins - The present invention relates to a process for the conversion of oxygenates to olefins comprising | 05-22-2014 |
Kirsten Strahlendorf, Toronto CA
Patent application number | Description | Published |
---|---|---|
20110229517 | SYSTEM AND PROCESS FOR PRODUCING MULTI-COMPONENT BIOPHARMACEUTICALS - A sterile, closed, disposable system for formulating biopharmaceutical compositions containing multiple active agents is described herein. | 09-22-2011 |
20160058666 | System and Process for Producing Mulit-Component Biopharmaceuticals - A sterile, closed, disposable system for formulating biopharmaceutical compositions containing multiple active agents is described herein. | 03-03-2016 |
Kirsten Unks, Solana Beach, CA US
Patent application number | Description | Published |
---|---|---|
20130085771 | METHOD OF DISPLAYING PATIENT DATA IN A MEDICAL WORKFLOW ENVIRONMENT - An apparatus, a method and a system for displaying patient data in a medical workflow environment are disclosed. The method includes scanning a patient identifier with a hand-held device, displaying patient data on a display screen of the hand-held device, selecting a medication for administration to the patient from a list of one or more medications displayed on the display screen, scanning a medication identifier with the hand-held device, and confirming administration of the medication on the hand-held device | 04-04-2013 |
Kirsten Van Fossen, Moorestown, NJ US
Patent application number | Description | Published |
---|---|---|
20120234694 | ELECTROCHEMICAL CARBON NANOTUBE FILTER AND METHOD - A filtration apparatus and filtration method can be used to reduce at least one contaminant (e.g., organic molecules, ions and/or biological microorganisms) in an aqueous fluid. The filtration apparatuses and methods of the invention can separate at least one contaminant from an aqueous fluid and/or oxidize at least one contaminant. In operation, an aqueous fluid is flowed through a filtration apparatus comprising a porous carbon nanotube filter material at an applied voltage. In some embodiments, the filtration apparatus described herein can be used for dead-end filtration. In some embodiments, the filtration apparatus described herein can be used for cross-over filtration. | 09-20-2012 |
Kirsten Völp, Karben DE
Patent application number | Description | Published |
---|---|---|
20130004513 | AGENTS FOR TREATING DISEASE - Provided are methods of screening to identify molecules capable of binding to CD4 and capable of activating CD4+CD25+ regulatory T cells. Further provided are antibodies and antibody fragments capable of activating CD4+CD25+ regulatory T cells and methods and uses involving the antibodies and fragments thereof. | 01-03-2013 |